Virtus LifeSci Biotech Clinical Trls ETF has Coefficient Of Variation of (939.34) and Risk Adjusted Performance of (0.13). Virtus LifeSci technical analysis provides you with the way to harness past market data to determine a pattern that measures the direction of the etf future prices. In other words you can use this information to find out if the etf will indeed mirror its model of past prices and volume data or the prices will eventually revert. We found nineteen technical drivers for Virtus LifeSci Biotech Clinical Trls ETF which can be compared to its competition. Please validate Virtus LifeSci BiotechValue At Risk, Expected Short fall and the relationship between Treynor Ratio and Downside Variance to decide if Virtus LifeSci is priced more or less accurately providing market reflects its prevalent price of 25.38 per share.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Virtus LifeSci Biotech volatility. High ATR values indicate high volatility, and low values indicate low volatility. View also all equity analysis or get more info about average true range volatility indicators indicator.
Virtus LifeSci Biotech Trend Analysis
Use this graph to draw trend lines for Virtus LifeSci Biotech Clinical Trls ETF. You can use it to identify possible trend reversals for Virtus LifeSci as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Virtus LifeSci price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.
Virtus LifeSci Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Virtus LifeSci Biotech Clinical Trls ETF applied against its price change over selected period. The best fit line has a slop of 0.03 % which may imply that the returns on investment in Virtus LifeSci Biotech Clinical Trls ETF will continue to fail. It has 78 observation points and a regression sum of squares at 7.43, which is the sum of squared deviations for the predicted Virtus LifeSci price change compared to its average price change.
Did you try this?
Run CEO Directory Now
Screen CEOs from public companies around the world